v3.25.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 5 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (3,612,993) $ (58,225,023)
Adjustments to reconcile net loss to net cash used in operating activities    
Allowances for credit losses 2,750,755 6,776,691
Day one loss on CPU Share Allocation Obligations 403,536
Change in fair value of CPU Share Allocation Obligations (10,768,381)
Change in fair value of July Investment Agreement Derivative 59,289,676
Paid in kind - interest (963,195)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (74,753)
Accounts payable (856,240)
Accrued expenses 211,316 (44,251)
Net cash used in operating activities (650,922) (4,461,940)
Cash flows from investing activities    
Issuance of notes receivable (1,083,294) (760,748)
Collection of notes receivable 200,000
Issuance of notes receivable, related party (1,000,000) (2,495,201)
Issuance of convertible notes receivable (2,500,000)
Net cash used in investing activities (4,583,294) (3,055,949)
Cash flows from financing activities    
Proceeds from issuance of member units 100
Proceeds from issuance of convertible preferred units 5,730,004 7,050,000
Payments for deferred transaction costs (532,507)
Net cash provided by financing activities 5,730,104 6,517,493
Net change in cash 495,888 (1,000,396)
Cash, beginning of period 2,614,710
Cash, end of period 495,888 1,614,314
Supplemental cash flow information:    
Taxes paid
Interest paid
Supplemental disclosure of noncash investing and financing activities:    
Fair value of CPU Share Allocation Obligations issued in connection with issuance of certain convertible preferred units 4,703,536
Deferred transaction costs included within accounts payable and accrued expenses $ 3,461,562